RMD three-lens brief
Evidence-based stock research on RMD. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 12.6pp over 30 days. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- Underperforming SPY by 12.6pp over 30 days.
- Analyst mean target $292.33 — 33% above current (15 analysts).
- Debt-to-equity of 13.4 — balance-sheet-heavy.
RMD closed at $219.85 (+0.15%) as of 2026-04-25. Market cap: $32.03B. P/E (trailing) 21.7. Positives: analyst mean target $292.33 — 33% above current (15 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; underperforming SPY by 12.6pp over 30 days.. Last quarter: Revenue $1.42B, net income $392.59M, free cash flow $1.42B.
Why three lenses on RMD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RMDacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RMD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RMD brief"></iframe>